Ownership history in Arax Advisory Partners · 3 quarters on record
This page tracks every 13F SEC filing in which Arax Advisory Partners reported a position in PRIME MEDICINE INC (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 5,406 | +5,267 | +3789.2% | 0.00% | $30K | $5.54 |
| 2024 Q3 | UNCHANGED | 139 | — | 0% | 0.00% | $538 | $3.87 |
| 2024 Q2 | INITIATED | 139 | — | — | 0.00% | $715 | — |
As of 2025 Q4 — sorted by position size